Eloxx finalizes Phase 2 ADPKD trial design, names new CMO

Go back to Eloxx finalizes Phase 2 ADPKD trial design, names new CMO
(NASDAQ: ELOX) Delayed: 13.30 --0 (-0%)
Previous Close $13.30    52 Week High $ 
Open $13.30    52 Week Low $ 
Day High $13.30    P/E N/A 
Day Low $13.30    EPS $ 
Volume 11